Ahmed Alnughmush

8PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersClinical chemistry (incl. diagnostics)HaematologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 25, 2026
Chromosome 1q Gain Defines a Plasma Cell-Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.

|Nov 03, 2025
Low (0.1% to ≤ 1%) or Very Low (0.06% to < 0.1%) JAK2V617F Allele Burden in Routine Testing: Clinical Correlates and Clonal Trajectory.

Ruah Alyamany, Ahmed Alnughmush, Oleksandr Klymenko

|Sep 18, 2025
Can we move beyond myeloablative conditioning (MAC)? A comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using ATG-PTCy-CSA for GVHD prophylaxis.

Ruah Alyamany, Ahmed Alnughmush, Mats Remberger

|May 29, 2025
Impact of Conditioning Intensity on Survival in Adult Patients (< 65 Years) With Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post-Transplantation Cyclophosphamide Based GVHD Prophylaxis.

Ahmed Alnughmush, Ruah Alyamany, Mats Remberger

|Jan 13, 2025
Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?

Ahmed Alnughmush, Ayman Sayyed, Mats Remberger

|Dec 27, 2024
Let It Grow: The Role of Growth Factors in Managing Chemotherapy-Induced Cytopenia.

Ruah Alyamany, Ahmed Alnughmush, Hazzaa Alzahrani

Pageof 2

Frequent Collaborators

3 joint publications

Ruah Alyamany

2 joint publications

Arjun Datt Law

2 joint publications

Dennis Dong Hwan Kim

2 joint publications

Fotios V Michelis